Literature DB >> 16749029

Biochemistry of dystrophic muscle. 2. Some enzyme changes in dystrophic mouse muscle.

R J Pennington1.   

Abstract

Entities:  

Year:  1963        PMID： 16749029      PMCID： PMC1203848          DOI： 10.1042/bj0880064

Source DB:  PubMed          Journal:  Biochem J        ISSN： 0264-6021            Impact factor:   3.857


× No keyword cloud information.
  15 in total

1.  Enzyme studies in muscular dystrophy. I. Muscle proteolytic activity and vitamin E-deficiency.

Authors:  I M WEINSTOCK; A D GOLDRICH; A T MILHORAT
Journal:  Proc Soc Exp Biol Med       Date:  1955-02

2.  Increased lysosomal enzymes in genetic muscular dystrophy.

Authors:  A L TAPPEL; H ZALKIN; K A CALDWELL; I D DESAI; S SHIBKO
Journal:  Arch Biochem Biophys       Date:  1962-02       Impact factor: 4.013

3.  Biochemistry of dystrophic muscle. Mitochondrial succinate-tetrazolium reductase and adenosine triphosphatase.

Authors:  R J PENNINGTON
Journal:  Biochem J       Date:  1961-09       Impact factor: 3.857

4.  Proteolytic activity of rat skeletal muscle. I. Evidence for the existence of an enzyme active optimally at pH 8.5 to 9.0.

Authors:  T R KOSZALKA; L L MILLER
Journal:  J Biol Chem       Date:  1960-03       Impact factor: 5.157

5.  Phosphoglucomutase activity in hereditary muscular dystrophy in mice.

Authors:  W R HAZZARD; S L LEONARD
Journal:  Proc Soc Exp Biol Med       Date:  1959 Oct-Dec

6.  Phosphorylase and glycogen levels in skeletal muscle of mice with hereditary myopathy.

Authors:  S L LEONARD
Journal:  Proc Soc Exp Biol Med       Date:  1957-12

7.  A spectrophotometric method for the determination of creatine phosphokinase and myokinase.

Authors:  I T OLIVER
Journal:  Biochem J       Date:  1955-09       Impact factor: 3.857

8.  Studies on the plasma proteins in the interstitial fluid of muscle.

Authors:  D GITLIN; C A JANEWAY
Journal:  Science       Date:  1954-09-17       Impact factor: 47.728

9.  Serum enzymes; variations of activity in disease of muscle.

Authors:  L P WHITE
Journal:  Calif Med       Date:  1959-01

10.  Enzyme studies in muscular dystrophy. III. In hereditary muscular dystrophy in mice.

Authors:  I M WEINSTOCK; S EPSTEIN; A T MILHORAT
Journal:  Proc Soc Exp Biol Med       Date:  1958-10
View more
  10 in total

1.  Scanning electron microscopy and cytochemical localization of carnitine acetyltransferase activity in normal and dystrophic muscle of mice.

Authors:  T Makita; S Kiwaki; E B Sandborn
Journal:  Histochem J       Date:  1973-07

2.  The determination of lactate dehydrogenase isoenzymes in normal human muscle and other tissues.

Authors:  A E Emery
Journal:  Biochem J       Date:  1967-11       Impact factor: 3.857

3.  Lysosomal activation in mouse skeletal muscle induced by protamine in vitro.

Authors:  R Libelius; I Lundquist
Journal:  Cell Tissue Res       Date:  1978-01-09       Impact factor: 5.249

4.  Protein degradation in skin fibroblasts from patients with Duchenne muscular dystrophy.

Authors:  H E Statham; J A Witkowski; V Dubowitz
Journal:  Biochem J       Date:  1980-10-15       Impact factor: 3.857

5.  Therapeutic trials in muscular dystrophy. 1. Gold in murine dystrophy.

Authors:  A Enomoto; W G Bradley
Journal:  J Neurol Neurosurg Psychiatry       Date:  1978-05       Impact factor: 10.154

6.  Protein synthesis in muscles from normal and dystrophic hamsters.

Authors:  M Saleem; D M Nicholls
Journal:  Biochem J       Date:  1979-04-15       Impact factor: 3.857

7.  Successful treatment of murine muscular dystrophy with the proteinase inhibitor leupeptin.

Authors:  J H Sher; A Stracher; S A Shafiq; J Hardy-Stashin
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

8.  Cell-free protein synthesis in heart and skeletal muscles from polymyopathic hamsters.

Authors:  A J Bester; W Gevers
Journal:  Biochem J       Date:  1973-02       Impact factor: 3.857

9.  In vivo effects of protease inhibitors on chickens with hereditary muscular dystrophy.

Authors:  M S Hudecki; C M Pollina; R R Heffner
Journal:  J Clin Invest       Date:  1981-04       Impact factor: 14.808

10.  Adenosine 5 -triphosphate--creatine phosphotransferase from dystrophic mouse skeletal muscle. A genetic lesion associated with the catalytic-site thiol group.

Authors:  B T Hooton; D C Watts
Journal:  Biochem J       Date:  1966-09       Impact factor: 3.857
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.